14-50911872-CTT-CT

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBA1

The NM_002863.5(PYGL):​c.1828-2delA variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 17685 hom., cov: 0)
Exomes 𝑓: 0.37 ( 107281 hom. )

Consequence

PYGL
NM_002863.5 splice_acceptor, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.00

Publications

16 publications found
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
  • glycogen storage disease VI
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.05581761 fraction of the gene. Cryptic splice site detected, with MaxEntScore 6.4, offset of 0 (no position change), new splice context is: gtttgaccttcttccccaAGgct. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 14-50911872-CT-C is Benign according to our data. Variant chr14-50911872-CT-C is described in ClinVar as Benign. ClinVar VariationId is 194627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.649 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002863.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGL
NM_002863.5
MANE Select
c.1828-2delA
splice_acceptor intron
N/ANP_002854.3
PYGL
NM_001163940.2
c.1726-2delA
splice_acceptor intron
N/ANP_001157412.1P06737-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGL
ENST00000216392.8
TSL:1 MANE Select
c.1828-2delA
splice_acceptor intron
N/AENSP00000216392.7P06737-1
PYGL
ENST00000532462.5
TSL:1
c.1828-2delA
splice_acceptor intron
N/AENSP00000431657.1E9PK47
PYGL
ENST00000874287.1
c.1843-2delA
splice_acceptor intron
N/AENSP00000544346.1

Frequencies

GnomAD3 genomes
AF:
0.460
AC:
69868
AN:
151864
Hom.:
17649
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.655
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.533
Gnomad ASJ
AF:
0.329
Gnomad EAS
AF:
0.624
Gnomad SAS
AF:
0.448
Gnomad FIN
AF:
0.360
Gnomad MID
AF:
0.472
Gnomad NFE
AF:
0.339
Gnomad OTH
AF:
0.454
GnomAD2 exomes
AF:
0.441
AC:
110756
AN:
251422
AF XY:
0.426
show subpopulations
Gnomad AFR exome
AF:
0.657
Gnomad AMR exome
AF:
0.655
Gnomad ASJ exome
AF:
0.338
Gnomad EAS exome
AF:
0.609
Gnomad FIN exome
AF:
0.359
Gnomad NFE exome
AF:
0.342
Gnomad OTH exome
AF:
0.407
GnomAD4 exome
AF:
0.371
AC:
542589
AN:
1461716
Hom.:
107281
Cov.:
0
AF XY:
0.372
AC XY:
270277
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.670
AC:
22419
AN:
33478
American (AMR)
AF:
0.640
AC:
28627
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.345
AC:
9004
AN:
26136
East Asian (EAS)
AF:
0.657
AC:
26102
AN:
39700
South Asian (SAS)
AF:
0.443
AC:
38168
AN:
86248
European-Finnish (FIN)
AF:
0.357
AC:
19091
AN:
53406
Middle Eastern (MID)
AF:
0.451
AC:
2603
AN:
5768
European-Non Finnish (NFE)
AF:
0.335
AC:
372531
AN:
1111868
Other (OTH)
AF:
0.398
AC:
24044
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
23232
46464
69697
92929
116161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12306
24612
36918
49224
61530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.460
AC:
69959
AN:
151982
Hom.:
17685
Cov.:
0
AF XY:
0.464
AC XY:
34462
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.656
AC:
27164
AN:
41430
American (AMR)
AF:
0.533
AC:
8145
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.329
AC:
1143
AN:
3472
East Asian (EAS)
AF:
0.623
AC:
3212
AN:
5158
South Asian (SAS)
AF:
0.447
AC:
2156
AN:
4820
European-Finnish (FIN)
AF:
0.360
AC:
3798
AN:
10560
Middle Eastern (MID)
AF:
0.480
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
0.339
AC:
23037
AN:
67952
Other (OTH)
AF:
0.453
AC:
955
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1762
3523
5285
7046
8808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.393
Hom.:
2272
Bravo
AF:
0.484
Asia WGS
AF:
0.542
AC:
1884
AN:
3478
EpiCase
AF:
0.346
EpiControl
AF:
0.350

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Glycogen storage disease, type VI (3)
-
-
3
not specified (3)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.0
Mutation Taster
=76/24
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11356035; hg19: chr14-51378590; COSMIC: COSV53585980; COSMIC: COSV53585980; API